Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology ...
The payment gives Aligos non-dilutive funding as it advances its pipeline of treatments for liver and viral diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results